Cannabis stocks are in focus today, with most of the action centered around U.S.-based multi-state operators (MSOs) after ...

Q1 was way below expectations, and the outlook has been diminished. The stock looks expensive to peers. Find out why TLRY ...

Aphria Inc. was founded in 2013 when the leaders saw a future in cannabis and decided to apply more than 60 years of commercial agriculture and greenhouse expertise to grow a few medical cannabis ...

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its ...

Tilray reported mixed results in its first full quarter after merging with Aphria. The company turned a profit — posting a better-than-expected $33.6 million in net income, but missed Wall ...

The market promised tremendous growth potential. Major players such as Canopy Growth (CGC), Aurora Cannabis (ACB), and Aphria (now part of Tilray Brands) quickly established themselves as industry ...

Aphria: 6 Aurora Cannabis: 6 Canopy Growth: 6 Hexo Corp: 6 Harvest Health & Recreation: 5 ...

Tilray rallied as much as 27.2% on Wednesday after the company announced plans to merge with Aphria and create the world's biggest marijuana company. The two firms announced Wednesday they agreed ...

The three largest publicly traded Canadian companies—Canopy Growth, Aurora Cannabis, and Aphria Inc., which all trade on the Toronto Stock Exchange—currently have market caps of approximately ...

In 2018, it became the first major cannabis stock to trade on U.S. exchanges. And after a 2020 merger with Aphria, it is now one of the largest companies in both the medical marijuana and ...

At Aphria RX, our German cultivation and processing facility, we received the very first commercial cannabis cultivation license and commercial distribution license issued in Germany under the new ...

This randomized, placebo-controlled trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from CINV despite standard anti-nausea treatments. Participants received ...